Cargando…

Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles

A unique characteristic of the African horse sickness virus (AHSV) major core protein VP7 is that it is highly insoluble, and spontaneously forms crystalline particles in AHSV-infected cells and when expressed in vitro. The aggregation of AHSV VP7 into these crystals presents many problems in AHSV v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bekker, Shani, Huismans, Henk, van Staden, Vida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331310/ https://www.ncbi.nlm.nih.gov/pubmed/35893692 http://dx.doi.org/10.3390/v14081624

Ejemplares similares

Investigating the Role of African Horse Sickness Virus VP7 Protein Crystalline Particles on Virus Replication and Release
por: Bekker, Shani, et al.
Publicado: (2022)

Characterising Non-Structural Protein NS4 of African Horse Sickness Virus
por: Zwart, Lizahn, et al.
Publicado: (2015)

Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus
por: Conradie, Andelé M., et al.
Publicado: (2016)

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
por: Kanai, Yuta, et al.
Publicado: (2014)

Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness
por: Durán‐Ferrer, Manuel, et al.
Publicado: (2018)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

Immune response of horses to inactivated African horse sickness vaccines
por: Rodríguez, Marina, et al.
Publicado: (2020)

Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
por: Rutkowska, Daria A., et al.
Publicado: (2019)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
por: Calvo-Pinilla, Eva, et al.
Publicado: (2018)

Evidence of Intragenic Recombination in African Horse Sickness Virus
por: Ngoveni, Harry G., et al.
Publicado: (2019)

African Horse Sickness Virus Serotype 1 on Horse Farm, Thailand, 2020
por: Bunpapong, Napawan, et al.
Publicado: (2021)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
por: Aksular, Mine, et al.
Publicado: (2018)

Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine
por: Chaiyabutr, Narongsak, et al.
Publicado: (2022)

Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
por: Lulla, Valeria, et al.
Publicado: (2016)

Immunogenicity of plant‐produced African horse sickness virus‐like particles: implications for a novel vaccine
por: Dennis, Susan J., et al.
Publicado: (2017)

A review of African horse sickness and its implications for Ireland
por: Thompson, Geoffrey M, et al.
Publicado: (2012)

Seroprevalence of African horse sickness in selected donkey populations in Namibia
por: Molini, Umberto, et al.
Publicado: (2020)

African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination
por: Castillo‐Olivares, Javier
Publicado: (2020)

Addressing the recent outbreak of African horse sickness in Lagos, Nigeria
por: Adesola, Ridwan Olamilekan, et al.
Publicado: (2023)

Horse Sickness
por: Smith, W. Ramsey
Publicado: (1902)

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
por: Alberca, Berta, et al.
Publicado: (2014)

Quantitative Risk Assessment for African Horse Sickness in Live Horses Exported from South Africa
por: Sergeant, Evan S., et al.
Publicado: (2016)

Transmission and Control of African Horse Sickness in The Netherlands: A Model Analysis
por: Backer, Jantien A., et al.
Publicado: (2011)

Re-emergence of bluetongue, African horse sickness, and other Orbivirus diseases
por: MacLachlan, N. James, et al.
Publicado: (2010)

Adaptive strategies of African horse sickness virus to facilitate vector transmission
por: Wilson, Anthony, et al.
Publicado: (2009)

African Horse Sickness: A Review of Current Understanding and Vaccine Development
por: Dennis, Susan J, et al.
Publicado: (2019)

Pathological features of African horse sickness virus infection in IFNAR(−/−) mice
por: Jones, Luke M., et al.
Publicado: (2023)

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model
por: Castillo-Olivares, Javier, et al.
Publicado: (2011)

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV
por: van de Water, Sandra G. P., et al.
Publicado: (2015)

Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan
por: Karamalla, Siham T., et al.
Publicado: (2018)

B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera
por: Mathebula, Evans M., et al.
Publicado: (2017)

Seroprevalence and Risk Factors of African Horse Sickness in Three Agroecological Zones of Cameroon
por: Ndebé, Mohamed M. F., et al.
Publicado: (2022)

The sero-prevalence and sero-incidence of African horse sickness and equine encephalosis in selected horse and donkey populations in Zimbabwe
por: Gordon, Stuart J.G., et al.
Publicado: (2017)

Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge
por: Lulla, Valeria, et al.
Publicado: (2017)

Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus
por: Bachanek-Bankowska, Katarzyna, et al.
Publicado: (2014)

Modelling African horse sickness emergence and transmission in the South African control area using a deterministic metapopulation approach
por: de Klerk, Joanna N., et al.
Publicado: (2023)

Correction: Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus
Publicado: (2014)

Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Where are the horses? With the sheep or cows? Uncertain host location, vector-feeding preferences and the risk of African horse sickness transmission in Great Britain
por: Lo Iacono, Giovanni, et al.
Publicado: (2013)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
por: Durán-Ferrer, Manuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9c46vji35o39jnm4imqdrt2ksf